Search research articles
Contact Us
Filters
Showing results (361-370 of 372) with videos related to
Page
of 38
Sort By:
Zhonghua Yi Xue Za Zhi
|
December 17, 2016
[Myoclonus and it's associated factors in Creutzfeldt-Jakob disease]
J Liu, H X Wang, L P Li, et al.
Genes, Chromosomes & Cancer
|
February 19, 2000
Identification of novel regions of allelic loss from a genomewide scan of esophageal squamous-cell carcinoma in a high-risk Chinese population
N Hu, M J Roth, M Polymeropolous, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 20, 2001
Frequent inactivation of the TP53 gene in esophageal squamous cell carcinoma from a high-risk population in China
N Hu, J Huang, M R Emmert-Buck, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 6, 2022
First-line nivolumab plus ipilimumab versus chemotherapy in patients with unresectable malignant pleural mesothelioma: 3-year outcomes from CheckMate 743
S Peters, A Scherpereel, R Cornelissen, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
March 13, 2023
Deficient chaperone-mediated autophagy in macrophage aggravates inflammation of nonalcoholic steatohepatitis by targeting Nup85
Miao Zhang, Si Y Tian, Shuo Y Ma, et al.
Cancer Research
|
December 5, 2000
Loss of annexin 1 correlates with early onset of tumorigenesis in esophageal and prostate carcinoma
C P Paweletz, D K Ornstein, M J Roth, et al.
Beijing Da Xue Xue Bao. Yi Xue Ban = Journal of Peking University. Health Sciences
|
June 20, 2017
[Relationship between glycemic control and visceral adiposity index among the patients with type 2 diabetes mellitus]
Y Y Cao, X Tang, K X Sun, et al.
ESMO Open
|
May 30, 2025
Nivolumab plus ipilimumab with chemotherapy as first-line treatment of patients with metastatic non-small-cell lung cancer: final, 6-year outcomes from CheckMate 9LA
D P Carbone, T-E Ciuleanu, M Cobo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 13, 2026
Nivolumab plus chemotherapy as first-line treatment for advanced gastric, gastroesophageal junction, and esophageal adenocarcinoma: 5-year follow-up results from CheckMate 649
Y Y Janjigian, K Shitara, J A Ajani, et al.
Zhonghua Fu Chan Ke Za Zhi
|
May 29, 2020
[Advices on standards of endometrial cancer screening]
M Yu, Y Xiang, X X Ma, et al.
Page
of 38
Search research articles
Search
Showing results (361-370 of 372) with videos related to
Sort By:
Page
of 38
Zhonghua Yi Xue Za Zhi
|
December 17, 2016
[Myoclonus and it's associated factors in Creutzfeldt-Jakob disease]
J Liu, H X Wang, L P Li, et al.
Genes, Chromosomes & Cancer
|
February 19, 2000
Identification of novel regions of allelic loss from a genomewide scan of esophageal squamous-cell carcinoma in a high-risk Chinese population
N Hu, M J Roth, M Polymeropolous, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 20, 2001
Frequent inactivation of the TP53 gene in esophageal squamous cell carcinoma from a high-risk population in China
N Hu, J Huang, M R Emmert-Buck, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 6, 2022
First-line nivolumab plus ipilimumab versus chemotherapy in patients with unresectable malignant pleural mesothelioma: 3-year outcomes from CheckMate 743
S Peters, A Scherpereel, R Cornelissen, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
March 13, 2023
Deficient chaperone-mediated autophagy in macrophage aggravates inflammation of nonalcoholic steatohepatitis by targeting Nup85
Miao Zhang, Si Y Tian, Shuo Y Ma, et al.
Cancer Research
|
December 5, 2000
Loss of annexin 1 correlates with early onset of tumorigenesis in esophageal and prostate carcinoma
C P Paweletz, D K Ornstein, M J Roth, et al.
Beijing Da Xue Xue Bao. Yi Xue Ban = Journal of Peking University. Health Sciences
|
June 20, 2017
[Relationship between glycemic control and visceral adiposity index among the patients with type 2 diabetes mellitus]
Y Y Cao, X Tang, K X Sun, et al.
ESMO Open
|
May 30, 2025
Nivolumab plus ipilimumab with chemotherapy as first-line treatment of patients with metastatic non-small-cell lung cancer: final, 6-year outcomes from CheckMate 9LA
D P Carbone, T-E Ciuleanu, M Cobo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 13, 2026
Nivolumab plus chemotherapy as first-line treatment for advanced gastric, gastroesophageal junction, and esophageal adenocarcinoma: 5-year follow-up results from CheckMate 649
Y Y Janjigian, K Shitara, J A Ajani, et al.
Zhonghua Fu Chan Ke Za Zhi
|
May 29, 2020
[Advices on standards of endometrial cancer screening]
M Yu, Y Xiang, X X Ma, et al.
Page
of 38